{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:11:08Z","timestamp":1760955068534},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.cca.2008.06.018","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T08:25:44Z","timestamp":1214468744000},"page":"26-32","source":"Crossref","is-referenced-by-count":12,"title":["Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities"],"prefix":"10.1016","volume":"396","author":[{"given":"Mari\u00eblle J.","family":"van Breemen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Speijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2008.06.018_bib1","series-title":"The metabolic basis of inherited disease","first-page":"2641","article-title":"Gaucher disease","author":"Beutler","year":"1995"},{"key":"10.1016\/j.cca.2008.06.018_bib2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2008.06.018_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2008.06.018_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cca.2008.06.018_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.cca.2008.06.018_bib6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2008.06.018_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cca.2008.06.018_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol Dis"},{"issue":"Suppl. 447","key":"10.1016\/j.cca.2008.06.018_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08035320510028102","article-title":"Clinical evaluation of biomarkers in Gaucher disease","volume":"94","author":"Deegan","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cca.2008.06.018_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s10545-006-0318-8","article-title":"CCL18: a urinary marker of Gaucher cell burden in Gaucher patients","volume":"29","author":"Boot","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cca.2008.06.018_bib11","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene: nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2008.06.018_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L","article-title":"Proteomics: a new approach to the study of disease","volume":"192","author":"Chambers","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.cca.2008.06.018_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0009-8981(01)00677-5","article-title":"Proteome analysis and its impact on the discovery of serological tumor markers","volume":"313","author":"Poon","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2008.06.018_bib14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(95)91037-9","article-title":"Individualised low-dose alglucerase therapy for type 1 Gaucher's disease","volume":"345","author":"Hollak","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2008.06.018_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2008.06.018_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F","article-title":"Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis","volume":"25","author":"Meiring","year":"2002","journal-title":"J Sep Sci"},{"key":"10.1016\/j.cca.2008.06.018_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/elps.1150180303","article-title":"Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients","volume":"18","author":"Rabilloud","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.cca.2008.06.018_bib18","doi-asserted-by":"crossref","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","article-title":"Proteolytic activity of human osteoclast cathepsin K: expression, purification, activation, and substrate identification","volume":"271","author":"Bossard","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2008.06.018_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2004.07.004","article-title":"Important role of cathepsin S in generating peptides for TAP-dependent MHC class I crosspresentation in vivo","volume":"21","author":"Shen","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2008.06.018_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cca.2008.06.018_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1074\/mcp.M600303-MCP200","article-title":"Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease","volume":"6","author":"Vissers","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cca.2008.06.018_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","article-title":"Differential exoprotease activities confer tumor-specific serum peptidome patterns","volume":"116","author":"Villanueva","year":"2006","journal-title":"J Clin Invest"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898108003197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898108003197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T16:40:07Z","timestamp":1588783207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898108003197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0009898108003197"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2008.06.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}